Enveda raises $130m to advance AI-driven plant based drug development
Artificial Intelligence (AI)-driven biotech Enveda Biosciences has raised $130m in a Series C funding round to accelerate its drug discovery and development programmes. The funding will enable Enveda to advance its pipeline of ten drug candidates, …